Tandem Diabetes Care (TNDM) Amortizatization of Intangibles (2020 - 2021)
Tandem Diabetes Care (TNDM) posted Amortizatization of Intangibles of -$223000.0 for Q3 2021, down 169.91% on a QoQ basis from $319000.0 in Q3 2020, and down 169.91% year-over-year from $319000.0 in Q3 2020.
Tandem Diabetes Care (TNDM) Amortizatization of Intangibles (2020 - 2021) Analysis & Trends
Tandem Diabetes Care's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at -$223000.0 for Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Tandem Diabetes Care | 1.17 Bn | 597.96 Mn | 136.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -223,000.00 |
| Sep 30, 2021 | -223,000.00 |
| Sep 30, 2020 | 319,000.00 |
| Sep 30, 2020 | 319,000.00 |